Greenlane Corp (GNLN) - Bozor qiymatining balans qiymatiga nisbati

Greenlane Holdings Inc (GNLN) tovar belgisi

Greenlane Holdings (GNLN) keng tarqalgan distribyutsiya tarmi tufayli premium veyping mahsulotlari segmentida ustunlikka ega. Kompaniya innovatsion fito-farmatsevtika yetkazib berish tizimlarini joriy etmoqda va IT yechimlarni ishlab chiqmoqda. Joriy omborxona restrukturizatsiyasi likvidlik tanqisligini bartaraf etish uchun mo'ljallangan. Joriy kitob qiymatiga nisbat ko'rsatkichi ushbu tendentsiyalarni tasdiqlaydi va 0.04 qiymati ushbu holatni aks ettiradi.

Greenlane Holdings (GNLN) - Bozor kapitallashuvining balans qiymatiga nisbati 04.07.2022dan 01.11.2026gacha
Greenlane Holdings Inc yetakchi tovari

Greenlane Holdings (GNLN) AQSh va Yevropa bozorlarida veyping va kannabis aksessuarlarining distribyutsiyasini kengaytirmoqda. GURU.Markets platformasidagi bozor kapitalizatsiyasining buxgalteriya qiymatiga nisbati kompaniyaning bozor qiymati va uning sof aktivlari o'rtasidagi farqni aks ettiradi. Ushbu ko'rsatkich investorlarning bozor kutuvlarini kompaniya aktivlarining haqiqiy qiymati bilan solishtiradi. Yuqori qiymatlar aktivning haddan tashqari sotib olinganligidan dalolat beradi, past nisbat esa aktivning qadrsizlanganligini yoki emitentning fundamental zaifligini ko'rsatishi mumkin.

Greenlane Holdings kimlar bilan raqobatlashadi

Indivior PLC (INDV) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati COLL|Bozor qiymatining balans qiymatiga nisbati Cronos Group|Kapitallashuvning balans qiymatiga nisbati CGC (Canopy Growth Corp)|Bozor kapitallashuvining balans qiymatiga nisbati HITI|Bozor kapitallashuvining balans qiymatiga nisbati auroramj.com (ACB)|Bozor qiymatining balans qiymatiga nisbati Achieve Life Sciences ACHV|Balans qiymatiga nisbatan bozor qiymati SKYE|Anebulo Pharmaceuticals, Inc. - Bozor kapitallashuvining balans qiymatiga nisbati|InterCure Ltd. (INCR) - Kapitallashuvning sof aktivlarga nisbati|nutriband.com (NTRB) - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Nasus Pharma (NSRX)|Kapitallashuvning sof aktivlarga nisbati IGC|MIRA: Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati FLGC|IMCC: Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati ADIL (Adial Pharmaceuticals, Inc.)|Bozor kapitallashuvining balans qiymatiga nisbati Artelo Biosciences Inc. ARTL|ENSC - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati TTNP (Titan Pharmaceuticals)|InMed Pharmaceuticals Inc. (INM) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Akanda Corp|ENVB (Enveric) - Bozor kapitallashuvining balans qiymatiga nisbati|BGXX - Bozor qiymatining xususiy kapitalga nisbati|Bozor qiymatining balans qiymatiga nisbati Hempacco (HPCO)